Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan

References

• Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.
   PubMed Web of Science ®Google Scholar
• Harabuchi Y, Kishibe K, Komabayashi Y. Clinical manifestations of granulomatosis with polyangiitis (GPA: Wegener's granulomatosis) in the upper respiratory tracts by otolaryngologists of Japan. Clin Exp Nephrol. 2013;17:663–6.
   PubMed Web of Science ®Google Scholar
• Nicklasson B, Stangeland N. Wegener's granulomatosis presenting as otitis media. J Laryngol Otol. 1982;96:277–80.
   PubMed Web of Science ®Google Scholar
• Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488–98.
   PubMed Web of Science ®Google Scholar
• Bradley PJ. Wegener's granulomatosis of the ear. J Laryngol Otol. 1983;97:623–6.
   PubMed Web of Science ®Google Scholar
• Dagum P, Roberson JB, Jr. Otologic Wegener's granulomatosis with facial nerve palsy. Ann Otol Rhinol Laryngol. 1998;107:555–9.
   PubMed Web of Science ®Google Scholar
• Bibas A, Fahy C, Sneddon L, Bowdler D. Facial paralysis in Wegener's granulomatosis of the middle ear. J Laryngol Otol. 2001;115:304–6.
   PubMed Web of Science ®Google Scholar
• Nikolaou AC, Vlachtsis KC, Daniilidis MA, Petridis DG, Daniilidis IC. Wegener's granulomatosis presenting with bilateral facial nerve palsy. Eur Arch Otorhinolaryngol. 2001;258:198–202.
   PubMed Web of Science ®Google Scholar
• Bucolo S, Torre V, Montemagno A, Beatrice F. Wegener's granulomatosis presenting with otologic and neurologic symptoms: clinical and pathological correlations. J Oral Pathol Med. 2003;32:438–40.
   PubMed Web of Science ®Google Scholar
• Jacobi D, Maillot F, Hommet C, Arsene S, Cottier JP, Lamisse F, et al. P-ANCA cranial pachymeningitis: a case report. Clin Rheumatol. 2005;24:174–7.
   PubMed Web of Science ®Google Scholar
• Drinias V, Florentzson R. Facial palsy and Wegener's granulomatosis. Am J Otolaryngol. 2004;25:208–12.
   PubMed Web of Science ®Google Scholar
• Preuss SF, Stenner M, Beutner D, Laudes M, Klussmann JP. Fatal course of Wegener's granulomatosis with bilateral otomastoiditis and bilateral facial nerve palsy. Otolaryngol Head Neck Surg. 2008;138:799–800.
   PubMed Web of Science ®Google Scholar
• Wierzbicka M, Szyfter W, Puszczewicz M, Borucki L, Bartochowska A. Otologic symptoms as initial manifestation of wegener granulomatosis: diagnostic dilemma. Otol Neurotol. 2011;32:996–1000.
   PubMed Web of Science ®Google Scholar
• Ono N, Yoshihiro K, Oryoji D, Matsuda M, Ueki Y, Uezono S, et al. Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Mod Rheumatol. 2013;23:554–63.
   PubMed Web of Science ®Google Scholar
• Gomez-Torres A, Tirado Zamora I, Abrante Jimenez A, Esteban Ortega F. Wegener's granulomatosis causing bilateral facial paralysis and deafness. Acta Otorrinolaringol Esp. 2013;64:154–6.
   PubMedGoogle Scholar
• Iqbal AM, Blackburn D, Rafiq M, Sharrack B. Wegener's granulomatosis presenting with multiple cranial nerve palsies and pachymeningitis. Pract Neurol. 2013;13:193–5.
   PubMedGoogle Scholar
• Mori A, Hira K, Hatano T, Okuma Y, Kubo S, Hirano K, et al. Bilateral facial nerve palsy due to otitis media associated with myeloperoxidase-antineutrophil cytoplasmic antibody. Am J Med Sci. 2013;346:240–3.
   PubMed Web of Science ®Google Scholar
• Maranhao AS, Chen VG, Rossini BA, Testa JR, Penido Nde O. Mastoiditis and facial paralysis as initial manifestations of Wegener's Granulomatosis. Braz J Otorhinolaryngol. 2012;78:80–6.
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Sakaguchi M, Deji N, Uzu T, Nishio Y, Kashiwagi A. The occurrence of sensorineural hearing loss in a patient with myeloperoxidase-anti-neutrophil cytoplasmic antibody-related microscopic polyangiitis. Rheumatol Int. 2007;27:503–5.
   PubMed Web of Science ®Google Scholar
• Iruku P, Karanth P, Tiu H, Kankam C, Shaheen K. Hearing loss and kidney dysfunction: finding a unifying diagnosis. Case Rep Med. 2013;2013:1–3.
   Google Scholar
• Byun JH, Lee JH, Choi IS. Churg-strauss syndrome presented with hearing impairment and facial palsy. Ann Rehabil Med. 2014;38:852–5.
   PubMedGoogle Scholar
• Yoshida N, Iino Y. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int. 2014;63:523–32.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Kishibe K, Tateyama K. Clinical features of 90 cases of otitis media with ANCA associated vasculitis. (In Japanese). Otol Jpn. 2014;24:53–61.
   Google Scholar
• Nagato T, Otaka R, Wada T, Kanai N, Harabuchi Y. Clinical images: otitis media and nasal granulation in Wegener's granulomatosis. Arthritis Rheum. 2009;60:379. doi:10.1002/art.24327.
   PubMed Web of Science ®Google Scholar
• Hirose O, Itabashi M, Takei T, Nitta K. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis. Mod Rheumatol. 2015;25:230–4.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, et al. Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms. Otol Neurotol. 2014;35:114–20.
   PubMed Web of Science ®Google Scholar
• Research Committee on Intractable Vasculitides tMoH, Labour and Welfare of Japan. In: Ozaki S, Makino H, Matsui K, editors. Clinical Practice Guideline for ANCA-associated Vasculittis Tokyo: Shinao Public Press; 2011:16–17; (In Japanese).
   Google Scholar
• Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222–7.
   PubMed Web of Science ®Google Scholar
• Sada KE, Yamamura M, Harigai M, Fujii T, Arimura Y, Makino H. Issues associated with the Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitides: reclassification of patients in the prospective cohort study of Remission Induction Therapy in Japanese patients with ANCA-associated vasculitides according to the MHLW criteria. Mod Rheumatol. 2015;25:657–9.
   PubMed Web of Science ®Google Scholar
• Sada KE, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014;16:R101.
   PubMed Web of Science ®Google Scholar
• Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, et al. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis. 2010;69:1934–9.
   PubMed Web of Science ®Google Scholar
• Ferri E, Armato E, Capuzzo P, Cavaleri S, Ianniello F. Early diagnosis of Wegener's granulomatosis presenting with bilateral facial paralysis and bilateral serous otitis media. Auris Nasus Larynx. 2007;34:379–82.
   PubMed Web of Science ®Google Scholar
• Magliulo G, Parrotto D, Alla FR, Gagliardi S. Acute bilateral facial palsy and Wegener's disease. Otolaryngol Head Neck Surg. 2008;139:476–7.
   PubMed Web of Science ®Google Scholar
• Drachman D. Neurological complications of Wegener's granulomatosis. Arch Neurol. 1969;8:145–55.
   Google Scholar
• Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993;33:4–9.
   PubMed Web of Science ®Google Scholar
• Yokoseki A, Saji E, Arakawa M, Kosaka T, Hokari M, Toyoshima Y, et al. Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain. 2014;137:520–36.
   PubMed Web of Science ®Google Scholar
• Akahoshi M, Yoshimoto G, Nakashima H, Miyake K, Inoue Y, Tanaka Y, et al. MPO-ANCA-positive Wegener's granulomatosis presenting with hypertrophic cranial pachymeningitis: case report and review of the literature. Mod Rheumatol. 2004;14:179–83.
   PubMedGoogle Scholar
• Lim EJ, Kim SH, Lee SH, Lee KY, Choi JH, Nam EJ, et al. Reversible sensorineural hearing loss due to pachymeningitis associated with elevated serum MPO-ANCA. Clin Exp Otorhinolaryngol. 2011;4:155–8.
   PubMed Web of Science ®Google Scholar
• Dekker PJ. Wegener's granulomatosis: otological aspects. J Otolaryngol. 1993;22:364–7.
   PubMedGoogle Scholar
• Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. Progression and management of Wegener's granulomatosis in the head and neck. Laryngoscope. 2012;122:1695–700.
   PubMed Web of Science ®Google Scholar
• Sriskandarajah V, Bansal RA, Yeoh R, Bansal AS. Early intervention in localized Wegener's granulomatosis with sensorineural hearing loss preserves hearing. Am J Audiol. 2012;21:121–6.
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford). 2011;50:1916–20.
   PubMed Web of Science ®Google Scholar
• Park J, Banno S, Sugiura Y, Yoshikawa K, Naniwa T, Wakita K, et al. Microscopic polyangiitis associated with diffuse panbronchiolitis. Intern Med. 2004;43:331–5.
   PubMed Web of Science ®Google Scholar
• Seidowsky A, Hoffmann M, Ruben-Duval S, Mesbah R, Masy E, Kyndt X, et al. Elastase-ANCA-associated idiopathic necrotizing crescentic glomerulonephritis – a report of three cases. Nephrol Dial Transplant. 2007;22:2068–71.
   PubMed Web of Science ®Google Scholar
• Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, et al. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Arthritis Res Ther. 2015;17:305. doi: 10.1186/s13075-015-0815-y.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68:310–17.
   PubMed Web of Science ®Google Scholar